Mounjaro's Price Has Gone Up — Here's What That Means for You

What changed in September 2025, and why private prices followed

Eli Lilly's UK list price increase in September 2025 was substantial and affected all Mounjaro strengths. Before the change, a single four-week pen at the highest dose was available at a list price of around £122; after 1 September 2025, that figure rose to around £330. Private clinics and pharmacies source from the licensed UK supply chain, so their retail prices moved in step. As reported at the time, typical private prices across providers now range roughly £149 to £375 per month depending on the dose and the service.

Those figures are hedged deliberately, they are market-wide and not static. If you're researching current Mounjaro pricing in the UK, you'll find variation between providers. Some of that reflects dose (a 2.5mg pen costs less than a 15mg pen); some reflects what's actually included in the quote. The increase has understandably made people more price-conscious, which makes it worth being careful about what a headline figure does and doesn't include.

Mounjaro is a Black Triangle (▼) medicine, under additional MHRA monitoring, and it remains a prescription-only medicine. The NICE appraisal of tirzepatide (TA1026) sets out the clinical evidence base; the clinical framework around it doesn't change because the list price did.

What a headline price often leaves out

The number quoted on a landing page is rarely the full cost of treatment. Some services charge separately for the initial consultation; others add a prescription fee, an administration fee, or a delivery charge on top of the medicine price. Aftercare (the clinical support between doses, and the re-review before you move to a higher dose) is sometimes bundled in, sometimes billed separately, and sometimes not offered at all.

None of this is hidden in bad faith, but it does mean two prices that look similar can represent quite different offers. A £199 quote that excludes delivery and consultation is a different proposition from a £225 quote that includes both, plus a prescriber review before each repeat. It's worth checking the small print before comparing numbers.

Dose increases also affect the maths. If you start on 2.5mg (the starter dose, designed to let your system adjust) and titrate upward over months, the cost per pen rises as the strength rises. Some providers quote the entry-level price prominently. If you want to understand what the Mounjaro 5mg pen costs as you move beyond the starter dose, that's a reasonable next step, but it won't be the price you pay at month six if your prescriber has moved your dose on.

What the higher price should be buying you

A legitimate Mounjaro prescription from a regulated UK pharmacy includes more than a pen in a box. It includes a clinical assessment by a qualified prescriber, a prescription issued only where appropriate, medicine sourced through the authorised UK supply chain, and enough aftercare that your prescriber can catch and address problems, including the gastrointestinal side effects that are common in the first weeks of each new dose.

At nume, one price covers the consultation, the prescription, the treatment, and free next-working-day delivery via DPD, you get a tracking link and a plain unbranded box arrives the following working day. There are no separate fees added afterward. A real clinician reads your consultation, not a decision algorithm. We're not the cheapest option on the market, and that's a deliberate position: we don't believe a prescription medicine is the right thing to undercut on price.

Our prescribers are GPhC-registered Independent Prescribers; you can verify our pharmacy on the GPhC register (premises number 9012878). For anyone uncertain about whether Mounjaro prices go up, the honest answer is that no one can predict Lilly's future pricing decisions, what you can control is choosing a regulated, transparent route now.

Why 'cheapest' is the wrong question to ask about a prescription medicine

The MHRA has repeatedly warned about counterfeit weight-loss pens circulating online and via social media. In October 2025, enforcement teams raided the first illicit UK manufacturing site producing fake tirzepatide pens, alongside seizures of around 20 million doses of illegally traded weight-loss medicines worth roughly £45m. Fake pens have in some cases contained insulin, a drug that at the wrong dose is acutely dangerous.

The red flags are consistent: sellers offering Mounjaro without a clinical assessment, prices far below the market range, and discount codes or voucher offers attached to a prescription medicine. No legitimate UK pharmacy runs promotion codes on a POM. If you're wondering whether Mounjaro prices will rise further, that uncertainty is another reason to be cautious about locking expectations to today's lowest figure rather than choosing a provider on the basis of clinical quality. The MHRA's Yellow Card scheme lets you report suspect sellers directly.

Price is a reasonable thing to think about, Mounjaro is not cheap, and the September 2025 increase made that more pronounced. But the relevant question isn't who charges the least; it's who provides a genuine clinical pathway, genuine medicine, and genuine support for what is, for most people, a months-long treatment. You can read more about how Mounjaro works or go straight to the free consultation when you're ready.